Floss-delivered vaccine protects mice, and human milk IgA limits a Th17-inducing gut bacterium in infants.
Vaccine antigen is coated onto dental floss thread and used to floss the two front teeth of a mouse. Braided thread trapped antigen in its gaps, so the group used a flat tape thread for even delivery. They bought the floss at CVS, and the mice were anesthetized.
Answered around 14:13At the base of the gingival sulcus sits junctional epithelium that is non-keratinized, so it has high permeability and an abundant amount of immune cells. That natural leakiness allows antigen entry into the blood and possibly the mucosal tissues there. The lead author learned about the sulcus reading off topic.
Answered around 14:36In a challenge model against influenza they do see protection, and enhanced protection over an intranasal vaccine. The mouse influenza model can be terminal, so this is probably systemic protection through increased systemic IgG. They did not do transmission studies, and the floss did not appear to raise salivary IgA.
Answered around 20:56Healthy volunteers aged 18 to 50 used a commercially available floss pick coated with blue food dye. 59% of the 100-microgram coating was delivered to the gingival sulcus, with some still remaining on the floss. 56% of participants flossed between 2 and 11 times, five passes being most common.
Answered around 22:55In surveys taken afterwards, 67% of the people said they would be more inclined to receive flu or coronavirus vaccines by floss. The hosts thought it could reduce anti-vax sentiment: easier than a pill, which is hard for kids, and the easiest option compared with an injection.
Answered around 24:10The discussion states it can only be used for individuals with teeth, which the hosts laughed at. That leaves out children up to about six months, who have no teeth, and older people with dentures rather than teeth, eliminating many elderly who need flu, RSV and COVID vaccines.
Answered around 25:39It is made by plasma cells that originate in the mother's gut, so there is a gut mammary gland axis alongside the brain-gut axis. Those antibodies target the gut microbiota in the mother and in the baby, because the same microbes colonize mom and the infant in the same environment.
Answered around 29:59Metagenomics of the baby fecal samples showed E. ramosum was the only species in the infant gut with a significant negative association with secretory IgA targeting. The group therefore focused on it, proposing that secretory IgA limits this species in the human gut, and then tested that hypothesis.
Answered around 39:33E. ramosum adheres hard to human CACO2 intestinal epithelial cells and induces cytoskeletal and actin rearrangement. Secretory IgA from 20 human milk samples with very high binding reduced that adherence. Heat-denatured antibody did not, and IgA purified from 20 samples with low binding capacity also failed to limit adherence.
Answered around 47:49E. ramosum did not adhere to murine intestinal cells, because mice do not carry this bacterium. Germ-free mice infected with it made no Th17 response in small intestine or colon, and specific-pathogen-free mice depleted with vancomycin and then fed the bacterium also failed to induce a Th17 response.
Answered around 50:39“You cannot do intense Psycom and have a lab.”
“how do you set up a oral vaccine or a mucosal vaccine and make sure that it doesn't lead to a tolerance response?”
“I think there's some significant challenges with actually implementing this, but I really love the creativity of it.”
“It can only be used for individuals with teeth.”
“Floss-Based Vaccination and IgA Protection.” https://traffic.libsyn.com/secure/immune/Immune096.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/floss-based-vaccination-and-iga-protection.html.